We use cookies for a better user experience. Read our Privacy Policy

I Agree

Radiodermatitis Market

Radiodermatitis Market (Product Type - Topical (Corticosteroids, Hydrophilic Creams, and Antibiotics), Oral Medication (Corticosteroids, Oral Analgesics, and Antibiotics), and Dressings (Hydrogel, Hydrocolloid, No Sting Barrier Film, Honey Impregnated Gauze, and Silicone Coated Dressing (GM-CSF Gauze and Silver Leaf Dressing); Distribution Channel - Hospital Pharmacy, Retail Pharmacy Store, and Online Store) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2019 - 2027

  • According to Transparency Market Research’s latest report on the global Radiodermatitis market   for the historical period 2017–2018 and forecast period 2019–2027, Rise in cancer incidence across globe, innovation leading to product offerings, growing partnerships and agreements amongst companies , collaboration between industry academia & industry-institutes, rising merger & acquisitions, entry of new players, and increase in access to health care are projected to drive the global Radiodermatitis Market .As per research, radiodermatitis likely to occur in more than 50% of the patients who underwent radiation therapy for cancer and it could rise up to 95% also.
  • According to the report, the global radiodermatitis market was valued at US$ 334.2 Mn in 2018 and is projected to expand at a CAGR of 3.3% from 2019 to 2027.
fa global radiodermatitis market

To know the scope of our report Get a Sample on Radiodermatitis Market

Rise in cancer incidence across globe and growing co-morbid conditions: Key Drivers

  • According to the WHO, the number of new cancer cases is expected to rise to 22 million by 2032, and 9.6 million deaths are estimated in the year 2018. As per International Agency for Research on Cancer (IARC), the global cancer burden increases with 18.1 million cases estimated new cases each year. In addition, the rate of certain types of cancers such as breast cancer and head and neck cancer is projected to escalate. This is attributable to faulty lifestyle factors such as obesity for breast cancer, and smoking for head and neck cancers. Moreover, the aforementioned cancers are treated with radiation at site. Hence, patients suffering from these cancers are more likely to develop radiation-induced dermatitis. Therefore, the overall spiral in cancer cases coupled with a surge in specific cancers due to faulty lifestyle is likely to propel the radiodermatitis market. As per WHO, statistics, growing tobacco consumption and alcohol abuse accounts for 40% of the cancer burden across European countries. Amongst which 20% of the cancer lead to deaths in the European region.
  • Increasing focus on research to find a standard pertinent treatment is also expected to propel the radiodermatitis market. The lack of standard care products in the market makes it a highly opportune condition for players to set their innovative product ideas on the path of commercial success. Radiodermatitis is a skin condition which affects cancer patients undergoing radiation therapy or combination of chemotherapy and radiation therapy.
  • Rise in the number of people suffering from diabetes and obesity rapidly puts them at an added risk of developing cancer. This factor is likely to drive the need of the radiation therapy and boost the radiodermatitis incidences. Old age and obesity are also risk factors for cancer, which is likely to rise the demand of radiodermatitis drugs. According to the CDC’s (Centers for Disease Control), in year 2018, the diabetes cases have risen to 34.2 million, which is likely to grow to in the world by 2030. This escalation will indicate that there is a larger pool of patients likely to develop cancer and they would have a higher chance of radiation-induced skin damage due to co-morbid condition.
  • Product sales in the radiodermatitis market naturally tend to be higher in regions where the number of cancer patients undergoing radiation therapy is high. Asia Pacific leads the world in the number of cancer cases and in the number of patients undergoing combination of chemotherapy and radiation therapy, or radiation therapy by itself. The reach of a number of novel products developed in North America and Europe is gradually expanding in these regions as well as the Middle East & Africa via partnerships for distribution. This is likely to propel future demand for radiodermatitis care products.

Higher Radiodermatitis Cost likely to Hamper Market

  • The burden of cost of cancer treatment is a concern in developing nations, where high cost of therapy leads to constraints in financial resources. Hence, high cost of products, especially dressings such as honey-impregnated dressings and silicone dressings, is likely to restrain the market. Moreover, availability of low cost locally-manufactured dressings in the emerging economies is expected to hamper the growth of branded and expensive dressings.
  • Moreover, In the United States, the treatment of Cancer drugs incurred expenses around US$100,000 and as per research, 63% of the cancer patients face financial crises during the course of the treatment. Thus, growing cost are likely to hamper the radiodermatitis market in coming years.

Get a glimpse of the in-depth analysis through our Report Brochure

Global Radiodermatitis Market: Competitive Landscape

  • This report profiles major players in the global radiodermatitis market based on various attributes such as company overview, financial overview, product portfolio, business strategies, and recent developments. The global radiodermatitis market is fragmented, with the presence of a number of international, regional players as well as local players. Various players operating in the global radiodermatitis market are
    • 3M
    • BMG Pharma
    • ConvaTec Inc
    • Integra Life Sciences
    • Intermed Pharmaceuticals
    • Molnlycke Health Care AB
    • Smith & Nephew
  • Stratpharma AG.

Global Radiodermatitis Market: Key Developments

Key players in the global radiodermatitis market are engaged in reimbursment scenarios, research & development, technological advancements, launch of new products, and acquisition & collaborative agreements with other companies. These strategies of key players are likely to fuel the growth of the global radiodermatitis market. A few expansion strategies adopted by players operating in the global radiodermatitis market are:

  • In April 2019, CIVCO Radiotherapy, expertise in offering high quality, patient centric radioactive solutions entered into collaboration with Stratpharma AG to expand their focus on wound care in radiation therapy patients. This is likely to focus on patient centric care and improve post procedure outcomes.
  • In July 2017, Stratpharma AG launched StrataXRT, the first and only topical film wound dressing product to manage radiation dermatitis. This product is innovative and flexible wound dressing product to promote rapid healing and post radiation therapy patients.

Expanding operations in future? To get the perfect launch ask for a custom report 

The report on the global Radiodermatitis Market discussed individual strategies, followed by company profiles of manufacturers of drugs for managing Radiodermatitis condition. The competitive landscape section has been included in the report to provide readers with a dashboard view and a company market share analysis of key players operating in the global Radiodermatitis Market.

Global Radiodermatitis Market - Segmentation

Product

  • Topical
    • Corticosteroids
    • Hydrophilic Creams
    • Topical Antibiotics
  • Oral Medication
    • Corticosteroids
    • Oral analgesics & Antibiotics
  • Dressings
    • Hydrogel
    • Hydrocolloid
    • No Sting Barrier Film
    • Honey Impregnated gauze
    • Silicone coated dressing
    • Others

Distribution Channel

  • Hospital Pharmacy
  • Retail Pharmacy Store
  • Online Store

Region

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa
Radiodermatitis Market

Interested in this report?
Get a FREE Brochure now!

Get Free Brochure

*Get Brochure Report (PDF) sent to your email within minutes

Frequently Asked Questions

What is the total market worth of radiodermatitis market?

The global radiodermatitis market was worth US$ 334.2 Mn and is projected to reach a value of US$ 506.3 Mn by the end of 2027

What is the anticipated CAGR of radiodermatitis market in forecast period?

Radiodermatitis market is anticipated to grow at a CAGR of 3.3% during the forecast period

Which region is expected to project highest market share in radiodermatitis market?

Asia Pacific accounted for a major share of the global radiodermatitis market

What are the key driving factors for growth of radiodermatitis market?

Radiodermatitis market is driven by rise in cancer cases and lifestyle factors contributing to cancer leading to radiodermatitis and Rise in adverse events during radiation with chemotherapy to drive market

Who are the key players in the global radiodermatitis market?

Key players in the global radiodermatitis market include 3M & Co., Acelity, BMG Pharma S.r.l., ConvaTec, DermaSciences Inc., Intermed Pharmaceuticals, Molnlycke Health Care, Smith & Nephew plc, Stratpharma AG

1. Preface

    1.1. Market Definition and Scope

    1.2. Market Segmentation

    1.3. Key Research Objectives

    1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global Radiodermatitis Market  

4. Market Overview

    4.1. Introduction

        4.1.1. Market Definition

        4.1.2. Industry Evolution / Developments

    4.2. Overview

    4.3. Market Dynamics

        4.3.1. Drivers

        4.3.2. Restraints

        4.3.3. Opportunities

    4.4. Global Radiodermatitis Market   Analysis and Forecast, 2017–2027

        4.4.1. Market Revenue Projections (US$ Mn)

    4.5. Value Chain  Analysis

5. Key Insights

    5.1. Disease Provenance across Region/Globally

    5.2.  Pipeline Analysis 

6. Global Radiodermatitis Market   Analysis and Forecast, by Product    

    6.1. Introduction & Definition

        6.1.1. Key Findings / Developments

    6.2. Global Radiodermatitis Market   Value Forecast, by Product  , 2017–2027

        6.2.1. Topical

            6.2.1.1. Corticosteroids

            6.2.1.2. Hydrophilic Creams

            6.2.1.3. Topical Antibiotics

        6.2.2. Oral Medication

            6.2.2.1. Corticosteroids

            6.2.2.2. Oral analgesics & Antibiotics

        6.2.3. Dressings

            6.2.3.1. Hydrogel

            6.2.3.2. Hydrocolloid

            6.2.3.3. No sting Barrier film

            6.2.3.4. Honey Impregnated gauze

            6.2.3.5. Silicone coated dressing

            6.2.3.6. Others

    6.3. Global Radiodermatitis Market   Attractiveness, by Product   

7. Global Radiodermatitis Market   Analysis and Forecast, by Distribution Channel 

    7.1. Introduction & Definition

        7.1.1. Key Findings / Developments

    7.2. Global Radiodermatitis Market   Value Forecast, by Distribution Channel , 2017–2027

        7.2.1. Hospital Pharmacy  

        7.2.2. Retail Pharmacy Store  

        7.2.3. Online Store 

    7.3. Global Radiodermatitis Market   Attractiveness, by Distribution Channel   

8. Global Radiodermatitis Market   Analysis and Forecast, by Region

    8.1. Key Findings

    8.2. Global Radiodermatitis Market   Value Forecast, by Region

        8.2.1. North America 

        8.2.2. Europe 

        8.2.3. Asia Pacific 

        8.2.4. Latin America 

        8.2.5. Middle East & Africa 

    8.3. Global  Radiodermatitis Market   Attractiveness, by Region

9. North America Radiodermatitis Market   Analysis and Forecast

    9.1. Introduction

        9.1.1. Key Findings

    9.2. North America Radiodermatitis Market   Value (US$ Mn) Forecast, by Product   , 2017–2027

        9.2.1. Topical

            9.2.1.1. Corticosteroids

            9.2.1.2. Hydrophilic Creams

            9.2.1.3. Topical Antibiotics

        9.2.2. Oral Medication

            9.2.2.1. Corticosteroids

            9.2.2.2. Oral analgesics & Antibiotics

        9.2.3. Dressings

            9.2.3.1. Hydrogel

            9.2.3.2. Hydrocolloid

            9.2.3.3. No sting Barrier film

            9.2.3.4. Honey Impregnated gauze

            9.2.3.5. Silicone coated dressing

            9.2.3.6. Others

    9.3. North America Radiodermatitis Market   Value (US$ Mn) Forecast, by Distribution Channel  , 2017–2027

        9.3.1. Hospital Pharmacy  

        9.3.2. Retail Pharmacy Store  

        9.3.3. Online Store  

    9.4. North America Radiodermatitis Market   Value (US$ Mn) Forecast, by Country, 2017–2027

        9.4.1. U.S.

        9.4.2. Canada

    9.5. North America Radiodermatitis Market   Attractiveness Analysis 

        9.5.1. By Product    

        9.5.2. By Distribution Channel   

        9.5.3. By Country

10. Europe Radiodermatitis Market   Analysis and Forecast

    10.1. Introduction

        10.1.1. Key Findings

    10.2. Europe Radiodermatitis Market   Value (US$ Mn) Forecast, by Product   , 2017–2027

        10.2.1. Topical

            10.2.1.1. Corticosteroids

            10.2.1.2. Hydrophilic Creams

            10.2.1.3. Topical Antibiotics

        10.2.2. Oral Medication

            10.2.2.1. Corticosteroids

            10.2.2.2. Oral analgesics & Antibiotics

        10.2.3. Dressings

            10.2.3.1. Hydrogel

            10.2.3.2. Hydrocolloid

            10.2.3.3. No sting Barrier film

            10.2.3.4. Honey Impregnated gauze

            10.2.3.5. Silicone coated dressing

            10.2.3.6. Others

    10.3. Europe Radiodermatitis Market   Value (US$ Mn) Forecast, by Distribution Channel  , 2017–2027

        10.3.1. Hospital Pharmacy  

        10.3.2. Retail Pharmacy Store  

        10.3.3. Online Store  

    10.4. Europe Radiodermatitis Market   Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027

        10.4.1. Germany

        10.4.2. U.K.

        10.4.3. France

        10.4.4. Spain

        10.4.5. Italy

        10.4.6. Rest of Europe 

    10.5. Europe Radiodermatitis Market   Attractiveness Analysis 

        10.5.1. By Product   

        10.5.2. By Distribution Channel   

        10.5.3. By Country/Sub-region

11. Asia Pacific Radiodermatitis Market   Analysis and Forecast

    11.1. Introduction

        11.1.1. Key Findings

    11.2. Asia Pacific Radiodermatitis Market   Value (US$ Mn) Forecast, by Product   , 2017–2027

        11.2.1. Topical

            11.2.1.1. Corticosteroids

            11.2.1.2. Hydrophilic Creams

            11.2.1.3. Topical Antibiotics

        11.2.2. Oral Medication

            11.2.2.1. Corticosteroids

            11.2.2.2. Oral analgesics & Antibiotics

        11.2.3. Dressings

            11.2.3.1. Hydrogel

            11.2.3.2. Hydrocolloid

            11.2.3.3. No sting Barrier film

            11.2.3.4. Honey Impregnated gauze

            11.2.3.5. Silicone coated dressing

            11.2.3.6. Others

    11.3. Asia Pacific Radiodermatitis Market   Value (US$ Mn) Forecast, by Distribution Channel  , 2017–2027

        11.3.1. Hospital Pharmacy  

        11.3.2. Retail Pharmacy Store  

        11.3.3. Online Store  

    11.4. Asia Pacific Radiodermatitis Market   Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027

        11.4.1. China

        11.4.2. Japan

        11.4.3. India

        11.4.4. Australia & New Zealand

        11.4.5. Rest of Asia Pacific 

    11.5. Asia Pacific Radiodermatitis Market   Attractiveness Analysis 

        11.5.1. By Product   

        11.5.2. By Distribution Channel   

        11.5.3. By Country/Sub-region

12. Latin America Radiodermatitis Market   Analysis and Forecast

    12.1. Introduction

        12.1.1. Key Findings

    12.2. Latin America Radiodermatitis Market   Value (US$ Mn) Forecast, by Product   , 2017–2027

        12.2.1. Topical

            12.2.1.1. Corticosteroids

            12.2.1.2. Hydrophilic Creams

            12.2.1.3. Topical Antibiotics

        12.2.2. Oral Medication

            12.2.2.1. Corticosteroids

            12.2.2.2. Oral analgesics & Antibiotics

        12.2.3. Dressings

            12.2.3.1. Hydrogel

            12.2.3.2. Hydrocolloid

            12.2.3.3. No sting Barrier film

            12.2.3.4. Honey Impregnated gauze

            12.2.3.5. Silicone coated dressing

            12.2.3.6. Others

    12.3. Latin America Radiodermatitis Market   Value (US$ Mn) Forecast, by Distribution Channel  , 2017–2027

        12.3.1. Hospital Pharmacy  

        12.3.2. Retail Pharmacy Store  

        12.3.3. Online Store  

    12.4. Latin America Radiodermatitis Market   Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027

        12.4.1. Brazil

        12.4.2. Mexico

        12.4.3. Rest of Latin America 

    12.5. Latin America Radiodermatitis Market   Attractiveness Analysis 

        12.5.1. By Product   

        12.5.2. By Distribution Channel  s 

        12.5.3. By Country/Sub-region

13. Middle East & Africa Radiodermatitis Market   Analysis and Forecast

    13.1. Introduction

        13.1.1. Key Findings

    13.2. Middle East & Africa Radiodermatitis Market   Value (US$ Mn) Forecast, by Product   , 2017–2027

        13.2.1. Topical

            13.2.1.1. Corticosteroids

            13.2.1.2. Hydrophilic Creams

            13.2.1.3. Topical Antibiotics

        13.2.2. Oral Medication

            13.2.2.1. Corticosteroids

            13.2.2.2. Oral analgesics & Antibiotics

        13.2.3. Dressings

            13.2.3.1. Hydrogel

            13.2.3.2. Hydrocolloid

            13.2.3.3. No sting Barrier film

            13.2.3.4. Honey Impregnated gauze

            13.2.3.5. Silicone coated dressing

            13.2.3.6. Others

    13.3. Middle East & Africa Radiodermatitis Market   Value (US$ Mn) Forecast, by Distribution Channel  , 2017–2027

        13.3.1. Hospital Pharmacy  

        13.3.2. Retail Pharmacy Store  

        13.3.3. Online Store  

    13.4. Middle East & Africa Radiodermatitis Market   Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027

        13.4.1. GCC Countries

        13.4.2. South Africa

        13.4.3. Rest of Middle East & Africa 

    13.5. Middle East & Africa Radiodermatitis Market   Attractiveness Analysis 

        13.5.1. By Product   

        13.5.2. By Distribution Channel   

        13.5.3. By Country/Sub-region

14. Competition Landscape

    14.1. Market Share Analysis

    14.2. Company Profiles

        14.2.1. 3M

            14.2.1.1. Company Overview (HQ, Business Segments, Employee Strength)

            14.2.1.2. Financial Overview 

            14.2.1.3. Growth Strategies

            14.2.1.4. SWOT Analysis

        14.2.2. BMG Pharma 

            14.2.2.1. Company Overview (HQ, Business Segments, Employee Strength)

            14.2.2.2. Growth Strategies

            14.2.2.3. SWOT Analysis

        14.2.3. ConvaTec Inc

            14.2.3.1. Company Overview (HQ, Business Segments, Employee Strength)

            14.2.3.2. Financial Overview 

            14.2.3.3. Growth Strategies

            14.2.3.4. SWOT Analysis

        14.2.4. Integra Life Sciences

            14.2.4.1. Company Overview (HQ, Business Segments, Employee Strength)

            14.2.4.2. Financial Overview 

            14.2.4.3. Growth Strategies

            14.2.4.4. SWOT Analysis

        14.2.5. Intermed Pharmaceuticals

            14.2.5.1. Company Overview (HQ, Business Segments, Employee Strength)

            14.2.5.2. Financial Overview 

            14.2.5.3. Growth Strategies

            14.2.5.4. SWOT Analysis

        14.2.6. Molnlycke Health Care AB

            14.2.6.1. Company Overview (HQ, Business Segments, Employee Strength)

            14.2.6.2. Financial Overview 

            14.2.6.3. Growth Strategies

            14.2.6.4. SWOT Analysis

        14.2.7. Smith & Nephew 

            14.2.7.1. Company Overview (HQ, Business Segments, Employee Strength)

            14.2.7.2. Financial Overview 

            14.2.7.3. Growth Strategies

            14.2.7.4. SWOT Analysis

        14.2.8. Stratpharma AG

            14.2.8.1. Company Overview (HQ, Business Segments, Employee Strength)

            14.2.8.2. Growth Strategies

            14.2.8.3. SWOT Analysis

List of Tables

Table 01: Global Plaque Modification Devices Market Value (US$ Mn) Forecast, by Product, 2017–2027

Table 02: Global Plaque Modification Devices Market Value (US$ Mn) Forecast, by Distribution Channel, 2017–2027

Table 03: Global Plaque Modification Devices Market Value (US$ Mn) Forecast, by Region, 2017–2027

Table 04: North America Plaque Modification Devices Market Value (US$ Mn) Forecast, by Product, 2017–2027

Table 05: North America Plaque Modification Devices Market Value (US$ Mn) Forecast, by Distribution Channel, 2017–2027

Table 06: North America Plaque Modification Devices Market Value (US$ Mn) Forecast, by Country, 2017–2027

Table 07: Europe Plaque Modification Devices Market Value (US$ Mn) Forecast, by Product, 2017–2027

Table 08: Europe Plaque Modification Devices Market Value (US$ Mn) Forecast, by Distribution Channel, 2017–2027

Table 09: Europe Plaque Modification Devices Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027

Table 10: Asia Pacific Plaque Modification Devices Market Value (US$ Mn) Forecast, by Product, 2017–2027

Table 11: Asia Pacific Plaque Modification Devices Market Value (US$ Mn) Forecast, by Distribution Channel , 2017–2027

Table 12: Asia Pacific Plaque Modification Devices Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027

Table 13: Latin America Plaque Modification Devices Market Value (US$ Mn) Forecast, by Product, 2017–2027

Table 14: Latin America Plaque Modification Devices Market Value (US$ Mn) Forecast, by Distribution Channel, 2017–2027

Table 15: Latin America Plaque Modification Devices Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027

Table 16: Middle East & Africa Plaque Modification Devices Market Value (US$ Mn) Forecast, by Product, 2017–2027

Table 17: Middle East & Africa Plaque Modification Devices Market Value (US$ Mn) Forecast, by Distribution Channel, 2017–2027

Table 18: Middle East & Africa Plaque Modification Devices Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027

List of Figures

Figure 01 : Global Radiodermatitis Market  Snapshot

Figure 02: Global Radiodermatitis Market  Value (US$ Mn) and Distribution, by Region, 2018 and 2027

Figure 03: Global Radiodermatitis Market  Value (US$ Mn) Forecast, 2017?2027

Figure 04: Global Radiodermatitis Market  Value Share, by Product   , 2018

Figure 05: Global Radiodermatitis Market  Value Share, by Distribution Channel    2018

Figure 06: Global Radiodermatitis Market  Value Share, by Region, 2018

Figure 07: Global Radiodermatitis Market  Value Share Analysis, by Product   , 2018 and 2027

Figure 08: Global Radiodermatitis Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Topical, 2017–2027

Figure 11: Global Radiodermatitis Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Corticosteroids, 2017–2027

Figure 12: Global Radiodermatitis Market  Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Hydrophilic Creams, 2017–2027

Figure 13: Global Radiodermatitis Market  Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Topical Antibiotics, 2017–2027

Figure 14: Global Radiodermatitis Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Oral Medication, 2017–2027

Figure 15: Global Radiodermatitis Market  Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Corticosteroids, 2017–2027

Figure 16: Global Radiodermatitis Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Oral analgesics & Antibiotics, 2017–2027

Figure 17: Global Radiodermatitis Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Dressings, 2017–2027

Figure 18: Global Radiodermatitis Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Hydrogel, 2017–2027

Figure 19: Global Radiodermatitis Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Hydrocolloid, 2017–2027

Figure 20: Global Radiodermatitis Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by No sting Barrier film, 2017–2027

Figure 21: Global Radiodermatitis Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Honey Impregnated gauze, 2017–2027

Figure 22: Global Radiodermatitis Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Silicone coated dressing, 2017–2027

Figure 23: Global Radiodermatitis Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Others, 2017–2027

Figure 24: Global Radiodermatitis Market  Attractiveness Analysis , by Product   , 2019–2027

Figure 25: Global Radiodermatitis Market  Value Share Analysis, by Distribution Channel    2018 and 2027

Figure 26: Global Radiodermatitis Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Hospital Pharmacy , 2017–2027

Figure 27: Global Radiodermatitis Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Retail Pharmacy Store  , 2017–2027

Figure 28: Global Radiodermatitis Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Online Store , 2017–2027

Figure 29: Global Radiodermatitis Market  Attractiveness Analysis , by Distribution Channel    2019–2027

Figure 30: Global Radiodermatitis Market  Snapshot, by Country/Sub-region

Figure 31: Global Radiodermatitis Market  Value Share Analysis, by Region 2018 and 2027

Figure 32: Global Radiodermatitis Market  Attractiveness Analysis , by Region, 2019–2027

Figure 33: North America Radiodermatitis Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, 2017–2027

Figure 34: North America Radiodermatitis Market  Value Share (%), by Product   , 2018 and 2027

Figure 35: North America Radiodermatitis Market  Attractiveness Analysis , by Product   , 2019–2027

Figure 36: North America Radiodermatitis Market  Value Share (%), by Distribution Channel    2018 and 2027

Figure 37: North America Radiodermatitis Market  Attractiveness Analysis , by Distribution Channel    2019–2027

Figure 38: North America Radiodermatitis Market  Value Share (%), by Country/ Sub-region, 2018 and 2027

Figure 39: North America Radiodermatitis Market  Attractiveness Analysis , by Country/ Sub-region, 2019–2027

Figure 40: Europe Radiodermatitis Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, 2017–2027

Figure 41: Europe Radiodermatitis Market  Value Share (%), by Product   , 2018 and 2027

Figure 42: Europe Radiodermatitis Market  Attractiveness Analysis , by Product   , 2019–2027

Figure 43: Europe Radiodermatitis Market  Value Share (%), by Distribution Channel    2018 and 2027

Figure 44: Europe Radiodermatitis Market  Attractiveness Analysis , by Distribution Channel    2019–2027

Figure 45: Europe Radiodermatitis Market  Value Share (%), by Country/Sub-region, 2018 and 2027

Figure 46: Europe Radiodermatitis Market  Attractiveness Analysis , by Country/Sub-region, 2019–2027

Figure 47: Asia Pacific Radiodermatitis Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, 2017–2027

Figure 48: Asia Pacific Radiodermatitis Market  Value Share (%), by Product  , 2018 and 2027

Figure 49: Asia Pacific Radiodermatitis Market  Attractiveness Analysis , by Product   , 2019–2027

Figure 50: Asia Pacific Radiodermatitis Market  Value Share (%), by Distribution Channel    2018 and 2027

Figure 51: Asia Pacific Radiodermatitis Market  Attractiveness Analysis , by Distribution Channel    2019–2027

Figure 52: Asia Pacific Radiodermatitis Market  Value Share (%), by Country/Sub-region, 2018 and 2027

Figure 53: Asia Pacific Radiodermatitis Market  Attractiveness Analysis , by Country/Sub-region, 2019–2027

Figure 54: Latin America Radiodermatitis Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, 2017–2027

Figure 55: Latin America Radiodermatitis Market  Value Share (%), by Product  , 2018 and 2027

Figure 56: Latin America Radiodermatitis Market  Attractiveness Analysis , by Product , 2019–2027

Figure 57: Latin America Radiodermatitis Market  Value Share (%), by Distribution Channel  2018 and 2027

Figure 58: Latin America Radiodermatitis Market  Attractiveness Analysis , by Distribution Channel    2019–2027

Figure 59: Latin America Radiodermatitis Market  Value Share (%), by Country/Sub-region, 2018 and 2027

Figure 60: Latin America Radiodermatitis Market  Attractiveness Analysis , by Country/Sub-region, 2019–2027

Figure 61: Middle East & Africa Radiodermatitis Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, 2017–2027

Figure 62 : Middle East & Africa Radiodermatitis Market  Value Share (%), by Product   , 2018 and 2027

Figure 63: Middle East & Africa Radiodermatitis Market  Attractiveness Analysis , by Product   , 2019–2027

Figure 64 : Middle East & Africa Radiodermatitis Market  Value Share (%), by Distribution Channel    2018 and 2027

Figure 65: Middle East & Africa Radiodermatitis Market  Attractiveness Analysis , by Distribution Channel    2019–2027

Figure 66: Middle East & Africa Radiodermatitis Market  Value Share (%), by Country/Sub-region, 2018 and 2027

Figure 67: Middle East & Africa Radiodermatitis Market  Attractiveness Analysis , by Country/Sub-region, 2019–2027

Transparency Market Research Plus
  • We offer 100% free customisation with our Enterprise License!!
  • Get a free copy if the report you purchased is updated within 90 days
  • Regardless from where you have purchased the report, you can request an updated version of the report from us.

Complete the form below and we'll get back to you shortly.

383

Your personal details are safe with us. Privacy Policy*

Copyright © Transparency Market Research, Inc. All Rights reserved